Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
65571 studies found for:    pharmacology
Show Display Options
Rank Status Study
1 Completed Tenofovir Pharmacology in Older HIV Infected Individuals
Conditions: HIV;   Aging
Intervention: Drug: iohexol
2 Completed Robotic Pharmacological Anesthesia System for Elective Cardiac Surgery
Condition: Cardiac Surgery
Intervention: Device: Test of pharmacologic anesthesia robot (labVIEW® software)
3 Completed Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: electrical cardioversion;   Drug: propafenone
4 Completed Abuse Liability and Human Pharmacology of Mephedrone
Condition: Amphetamine-Related Disorders
Interventions: Drug: Mephedrone;   Drug: 3,4-methylenedioxymethamphetamine;   Drug: Placebo
5 Recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
6 Completed Pharmacological Aids for Interactive Smoking Cessation
Condition: Smoking Cessation
Interventions: Behavioral: Smokefree Partners: 21 Days to Freedom;   Other: Wait-List Control
7 Completed A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers
Condition: Osteoarthritis
Interventions: Drug: ONO-4474 Part A1;   Drug: Placebo Part A1;   Drug: ONO-4474 Part A2;   Drug: Placebo Part A2;   Drug: ONO-4474 Part B;   Drug: Placebo Part B;   Drug: ONO-4474 Part C;   Drug: Placebo Part C;   Drug: ONO-4474 Part D;   Drug: Placebo Part D
8 Completed Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa
Condition: Healthy
Interventions: Drug: Kinetics of plasma concentrations of paracetamol;   Drug: Placebo
9 Completed Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Condition: Healthy
Interventions: Drug: MDA;   Drug: Placebo
10 Recruiting The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants
Condition: Persistent Ductus Arteriosus
Interventions: Procedure: Surgical treatment;   Drug: Control group
11 Completed A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Paliperidone palmitate
12 Unknown  Behavioral Pharmacology Associated With Cigar Smoking
Condition: Cigar Smoking
Intervention: Other: Smoking topography
13 Completed A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects
Condition: Clinical Pharmacology
Interventions: Drug: TAK-233;   Drug: Placebo
14 Withdrawn Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
15 Withdrawn Pharmacology of Exenatide in Pediatric Sepsis
Conditions: Septic Shock;   Inflammation;   Glucose Homeostasis;   Organ Dysfunction;   Health-related Quality of Life
Interventions: Drug: Exenatide;   Drug: Exenatide vehicle
16 Completed
Has Results
Study of Pharmacology of 17-OHPC in Pregnancy
Condition: Pregnancy
Interventions: Drug: 17-OHPC;   Procedure: Blood Draws
17 Completed Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors;   Lymphomas
Intervention: Drug: Camptothecin-20-O-Propionate Hydrate (CZ48)
18 Completed Clinical Biological and Pharmacological Factors Influencing Stroke Outcome
Condition: Stroke
Intervention:
19 Completed Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
20 Completed Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
Condition: Asthma
Interventions: Drug: Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1;   Drug: CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).;   Drug: BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF);   Drug: CHF 1535 100/6 pMDI (Foster®) (CTR)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years